299180-15-7

Basic information

• Product Name: 2H-Indazole-5-methanamine, 4,5,6,7-tetrahydro-
• CAS NO: 299180-15-7
• Molecular Formula: C₈H₁₃N₃
• Molecular Weight: 151.21
• Mol File: 299180-15-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2H-Indazole-5-methanamine, 4,5,6,7-tetrahydro-(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-Indazole-5-methanamine, 4,5,6,7-tetrahydro-(299180-15-7)
• EPA Substance Registry System: 2H-Indazole-5-methanamine, 4,5,6,7-tetrahydro-(299180-15-7)

Safety Data

• Hazardous Substances Data: 299180-15-7(Hazardous Substances Data)

Upstream product

• 299180-13-5 (+/-)-N-(4,5,6,7-tetrahydro-2H-indazol-5-ylmethyl)acetamide 
• 74197-10-7 (+/-)-5-ethanamido-4,5,6,7-tetrahydroindazole 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 30482-25-8 (1,4-dioxa-spiro[4.5]dec-8-yl)-methyl-amine 
• 30482-18-9 N-[(4-oxo-cyclohexyl)methyl]acetamide 
• 69947-09-7 1,4-dioxaspiro<4.5>decane-8-carbonitrile 
• 299180-11-3 N-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)acetamide 

Relevant articles and documents

A general synthesis of novel conformationally restricted arginine side- chain mimetics

6-(Aminomethyl)-5,6,7,8-tetrahydro-2-quinazolinamine and 4,5,6,7- tetrahydro-2H-indazol-5-ylmethan-amine were synthesized as novel conformationally restricted arginine side-chain mimetics, designed for incorporation into trypsin-like serine protease inhibitors. (C) 2000 Elsevier Science Ltd.

Anticoagulant contrast media

The present invention provides novel anticoagulant contrast agents, which comprise an organic scaffolding moiety, an organic anticoagulant moiety, and an imaging moiety. The invention also provides anticoagulant contrast media and methods of visualizing internal structures utilizing the novel anticoagulant contrast agents and anticoagulant contrast media.